RF Safe publishes an advocacy guide arguing that current wireless RF/MW exposure limits are “thermal-only,” outdated since 1996, and insufficient to address claimed non-thermal biological effects from pulsed/modulated signals. The guide summarizes mechanistic arguments (e.g., voltage-gated ion channel timing disruption), cites animal studies and reviews it says link RF exposure to cancer and other harms, and calls for regulatory and technological reforms (including Li‑Fi) plus exposure-reduction strategies. The piece frames the issue as urgent and precautionary, presenting its synthesis as evidence-grounded but primarily as advocacy rather than a single new study.

RF Safe argues that an FDA-authorized therapeutic radiofrequency device (TheraBionic P1) demonstrates biologically meaningful “non-thermal” RF effects, and contrasts this with consumer wireless regulation that it says is based primarily on heating (SAR) limits set in 1996. The post frames this as a regulatory and legal gap, citing the Radiation Control for Health and Safety Act and Telecommunications Act Section 704 as factors limiting local and public-health oversight. It also references several epidemiology and animal studies (e.g., Interphone, Hardell, CERENAT, IARC 2011 classification, and the U.S. NTP rodent studies) to support the claim that non-thermal effects and health risks warrant stronger scrutiny, though the article’s presentation is advocacy-oriented.

This RF Safe article argues that real-world, pulsed/modulated RF exposures may introduce “timing noise” that disrupts voltage-gated ion channel (VGIC) gating via the S4 helix, framing this as a non-thermal mechanism (“S4 Timing Fidelity”). It claims such timing drift could alter calcium and proton flux, affect cellular signaling and mitochondrial workload, and contribute to chronic oxidative stress and inflammatory pathway activation. The post further links this proposed mechanism to interpretations of large-animal RF studies (e.g., NTP and Ramazzini) as consistent with sub-thermal carcinogenic outcomes, presenting this as a unifying explanatory model rather than reporting new experimental results.

RF Safe argues that non-thermal RF-EMF effects on biology may be driven by extremely low-frequency (ELF) components embedded in real-world, modulated wireless signals rather than by the RF carrier alone. The post highlights Panagopoulos’ ion-forced-oscillation (IFO) model as a proposed mechanism in which ELF-related ion motion could perturb voltage-gated ion channel (VGIC) gating and cascade into oxidative stress and immune effects. It cites a mix of supportive and null findings and frames electromagnetic hypersensitivity (EHS) as a threshold/phenotype within the same proposed VGIC–mitochondria–ROS pathway.

RF Safe argues that non-thermal biological effects from low-frequency/pulsed RF-EMF exposures can be explained by a “timing-fidelity” mechanism involving voltage-gated ion channel (VGIC) gating perturbations. The post links altered ion-channel timing to downstream immune signaling changes (e.g., Ca²⁺ dynamics, NFAT/NF-κB transcription), mitochondrial stress, and inflammatory pathway activation, and suggests this could relate to reported animal cancer signals and reproductive endpoints. It proposes a set of “falsifiable tests” and calls for a policy/engineering program (“Clean Ether Act”) emphasizing RF temporal patterning and shifting some connectivity to LiFi.

This review argues that current mobile-telephony safety guidelines address excessive microwave heating but may not account for potential non-thermal influences of low-intensity, pulsed radiation. It highlights an asserted oscillatory similarity between pulsed microwave signals and certain electrochemical activities in humans as a reason for concern. While acknowledging uncertainty about health consequences, it notes reported consistencies between some non-thermal effects and neurological problems described by some users and people with long-term base-station exposure.